Global Regenerative Medicine Market was valued at US$ 28.50 Bn in 2020, estimated to reach US$ 155.40 Bn in 2027 with a CAGR of 23.41% from 2021-2027.
Market Drivers: Rising occurrence of chronic diseases, genetic disorders, and cancer
Over the last few decades, the occurrence of chronic diseases such as cardiovascular diseases, cancer, diabetes, ulcers, and genetic disorders such as cystic fibrosis have increased significantly across the globe. Diseases such as diabetes and obesity can result in the increased incidence and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and surgical wounds, which require treatments and incur excessive medical expenses. For instance, according to International Diabetes Federation (IDF), in 2019, a total of 463 million people were estimated to be living with diabetes, representing 9.3% of the global adult population (20–79?years). This number is expected to increase to 578 million (10.2%) in 2030 and 700 million (10.9%) in 2045. The prevalence of diabetes in women in 2019 was estimated to be 9.0%, and 9.6% in men. Therefore, innovation of regenerative medicines have helped the healthcare industry to address the challenges of growing chronic disorders.
Request a Sample Copy of the Research Report @ https://qualiketresearch.com/request-sample/Regenerative-Medicine-Market/request-sample
The key operating players in the Regenerative Medicine market are also discussed in the report to provide readers with a comprehensive overview of the competitive landscape in the overall market. The major strategies used by these companies in the Regenerative Medicine market are studied in the report to offer readers with an idea of what works & what doesn’t, in the Regenerative Medicine market. Individual players are examined in detail in the report in order to elaborate on their regional presence as well as product catalogue, providing a clear picture of each major player operating in the Regenerative Medicine market.
Market key Players
Various leading players are listed in this report such as Acelity Holdings, Inc. (Lifecell Corporation), Athersys, Inc., Cryolife, Inc., Integra Lifesciences Corporation, IstoBiologics (IstoBiologics Medical Systems, Inc.), Medtronic Plc, Organogenesis Inc., Stryker Corporation, Stem Cell, Inc. (Bioheart, Inc.), Zimmer Biomet Holdings, Inc., etc.
Get Discount On This Report @ https://qualiketresearch.com/request-sample/Regenerative-Medicine-Market/ask-for-discount
Market Segmentation
By Product
- Tissue-engineered Products
- Cell Therapies
- Gene Therapies
- Progenitor & Stem Cell Therapies
By Application
- Musculoskeletal
- Oncology
- Wound Care
- Dental
- Ocular
- Other Applications
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Inquire To Know More About This Report @ https://qualiketresearch.com/request-sample/Regenerative-Medicine-Market/inquire-before-buying